Skip to main content

Drug Interactions between bexarotene topical and Clinique Acne Solutions Spot Treatment

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

salicylic acid topical bexarotene topical

Applies to: Clinique Acne Solutions Spot Treatment (salicylic acid topical) and bexarotene topical

GENERALLY AVOID: Concomitant use of retinoids and keratolytic or astringent topicals may result in excessive irritation and/or drying.

MANAGEMENT: Depending on circumstances (e.g., areas of application), concomitant use should preferably be avoided, and a rest period considered in between use of these products.

References

  1. (2001) "Product Information. Retin-A (tretinoin)." Ortho McNeil Pharmaceutical
  2. (2001) "Product Information. Tazorac (tazarotene topical)." Allergan Inc

Switch to consumer interaction data

Drug and food interactions

No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.